We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Drugstore.Com, Inc. (MM) | NASDAQ:DSCM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.79 | 0 | 00:00:00 |
The Law Office of Abe Shainberg is investigating the Board of Directors of drugstore.com, inc. (Nasdaq: DSCM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Walgreen Company (NYSE: WAG). Under the terms of the proposed transaction, drugstore.com shareholders will receive $3.80 in cash per share for a total value of approximately $409 million.
The investigation concerns whether the drugstore.com Board of Directors breached their fiduciary duties to drugstore.com stockholders by failing to adequately shop the Company before entering into this transaction and whether Walgreen Company is underpaying for drugstore.com shares. On March 25, 2011, drugstore.com stock traded as high as $3.94 per share.
If you own common stock in drugstore.com and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at as@ashainberglaw.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/drugstore-dot-com-dscm.html.
Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
1 Year Drugstore Chart |
1 Month Drugstore Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions